Position history for BNP PARIBAS FINANCIAL MARKETS's holdings in SYNDAX PHARMACEUTICALS INC
BNP PARIBAS FINANCIAL MARKETS holds 14,228 shares of SNDX (SYNDAX PHARMACEUTICALS INC), worth $298,930 as of 2025-Q4. The position was decreased (-97.6% shares). SNDX represents 0.0% of BNP PARIBAS FINANCIAL MARKETS's portfolio.
Current Value
$298,930
Current Shares
14,228
Total Value Change
+$207,859
Total Shares Change
+9,792
Other major holders of SNDX: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Decreased |
| 14,228 |
-97.6% |
| $298,930 |
| 0.0% |
| $20.74 |
0 |
| 2025-Q3 | Increased | 599,871 | +20.0% | $9.2M | 0.0% | $15.56 | 33 |
| 2025-Q2 | Increased | 499,903 | +130.4% | $4.7M | 0.0% | $9.04 | 43 |
| 2025-Q1 | Decreased | 216,993 | -16.3% | $2.7M | 0.0% | $13.18 | 0 |
| 2024-Q4 | Increased | 259,245 | +1128.7% | $3.4M | 0.0% | $12.52 | 43 |
| 2024-Q3 | Increased | 21,099 | +375.6% | $406,156 | 0.0% | $18.89 | 38 |
| 2024-Q2 | Decreased | 4,436 | -90.3% | $91,071 | 0.0% | $20.53 | 0 |